Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer

NCT03087071 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

59

Enrollment

OTHER

Sponsor class

Conditions

EGFR NP_005219.2:p.S492R
KRAS Gene Mutation
MAP2K1 Gene Mutation
Metastatic Colorectal Adenocarcinoma
Refractory Colorectal Adenocarcinoma
Stage IV Colorectal Cancer AJCC v7
Stage IVA Colorectal Cancer AJCC v7
Stage IVB Colorectal Cancer AJCC v7

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Panitumumab
DRUG: Trametinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]